Maker of Dettol, Harpic, and other hygiene product manufacturers, Reckitt has announced its quarter 1 earnings for 2025. The company reported robust growth in the Indian market. According to Reckitt’s Q1 earnings data, the company posted single-digit growth in India, driven by strength in dental and Harpic. Besides, Reckitt witnessed some really strong volume growth in germ protection and intimate wellness spaces.
The company has expected sustained strong volume growth in India and other emerging markets in the upcoming quarters.
Chris Licht, CEO of Reckitt said, “Our businesses have very good momentum. We are launching a lot of successful innovation into the market and we’re scaling other innovation platforms. And so we absolutely expect that to continue. Now, of course, these economies may also not be immune to any shocks that could roll through the global economy. But as we sit here today, we fully expect sustained strong volume growth in China and India and in other emerging markets as we go through this year”.
Overall, Reckitt Benckiser Group PLC reported a modest start to 2025, with revenue growth of 1.1% in the first quarter, driven by strong performance in emerging markets.
Emerging markets strengthened the consumer health and hygiene company achieved a 10.7% increase in net revenue despite challenges in North America and Europe.
“We have delivered a solid start to 2025 with our overall Q1 performance in line with the guidance provided in March. A core record delivered 3.1% like-for-like net revenue growth and volume growth of plus 0.3%, closer to 1% when excluding the SAP pull-forward impact in Q1 last year. Emerging Markets was especially strong, reflecting improved in-market execution, double-digit growth in intimate wellness, Dettol and BMS, and continued momentum in China and India,” Licht said.